ALNY

#340
Alnylam Pharmaceuticals, Inc. - Common Stock
301.9 7 USD
-0.73%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
297.62
302.68
Year Range
284.28
495.55
Daily Change
-0.73%
Monthly Change
-1.79%
6 month change
-32.88%
Year Change
+5.14%
Previous Close
304.2 0
Open
297.7 2
Low
297.6 2
High
302.6 8
Volume
1 979
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

News